Search Results - Deusen, Kelsey Van

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer – A real world experience

    A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer... by Phelps, Megan K, Wiczer, Tracy E, Erdeljac, H Paige, Van Deusen, Kelsey R, Porter, Kyle, Philips, Gary, Wang, Tzu-Fei

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4 + T-cells

    A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4 + T-cells by Mates, Jessica M, de Silva, Suresh, Lustberg, Mark, Van Deusen, Kelsey, Baiocchi, Robert A, Wu, Li, Kwiek, Jesse J

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Comparison of Direct Oral Anticoagulants Versus Low-Molecular-Weight-Heparins for the Treatment of Cancer Associated Thrombosis

    Comparison of Direct Oral Anticoagulants Versus Low-Molecular-Weight-Heparins for the Treatment of Cancer Associated Thrombosis by Phelps, Megan K, Wiczer, Tracy E, Erdeljac, H. Paige, Van Deusen, Kelsey R, Porter, Kyle, Phillips, Gary, Wang, Tzu-Fei

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4⁺ T-cells

    A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4⁺ T-cells by Jessica M. Mates, Suresh de Silva, Mark Lustberg, Kelsey Van Deusen, Robert A. Baiocchi, Li Wu, Jesse J. Kwiek

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    A novel histone deacetylase inhibitor, AR-42, reactivates HIV-1 from chronically and latently infected [CD4.sup.+] T-cells

    A novel histone deacetylase inhibitor, AR-42, reactivates HIV-1 from chronically and latently infected [CD4.sup.+] T-cells by Mates, Jessica M, de Silva, Suresh, Lustberg, Mark, Van Deusen, Kelsey, Baiocchi, Robert A, Kwiek, Jesse J

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4^sup +^ T-cells

    A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4^sup +^ T-cells by Mates, Jessica M, Silva, Suresh de, Lustberg, Mark, Deusen, Kelsey Van, Baiocchi, Robert A, Wu, Li, Kwiek, Jesse J

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: